Mucormycosis

Keyphrases

• Mucormycosis 100%
• Clinical Presentation 66%
• Mucorales 66%
• Immunosuppression 66%
• Risk Factors 33%
• Sinusitis 33%
• Poor Outcome 33%
• Delayed Diagnosis 33%
• Randomized Trial 33%
• Necrosis 33%
• Fungi 33%
• Trauma 33%
• Immunocompromised Patients 33%
• Antifungal Agents 33%
• Posaconazole 33%
• Triazole 33%
• Necrotic Tissue 33%
• Gastrointestinal Tract 33%
• Metabolic Abnormalities 33%
• Angioinvasion 33%
• Affected Area 33%
• Clinical Suspicion 33%
• Immune Suppression 33%
• Aggressive Surgical Resection 33%
• Proclivity 33%
• Amphotericin B 33%
• Uncommon Presentation 33%
• Rapid Diagnostic Test 33%
• Higher Index 33%
• Uncontrolled Diabetes 33%
• Recent Introduction 33%
• Rhinocerebral 33%
• Localized Infection 33%
• Radiologic Presentation 33%
• Pansinusitis 33%
• Isavuconazole 33%
• Rhino-orbital 33%
• Histopathology 33%
• Tissue Infarction 33%

Medicine and Dentistry

• Mucormycosis 100%
• Immunosuppressive Treatment 100%
• Infection 66%
• Sinusitis 66%
• Biopsy Technique 33%
• Necrosis 33%
• Diabetes 33%
• Histopathology 33%
• Delayed Diagnosis 33%
• Immunocompromised Patient 33%
• Infarction 33%
• Antifungal Agent 33%
• Amphotericin B 33%
• Triazole Derivative 33%
• Posaconazole 33%
• Rapid Diagnostic Test 33%
• Isavuconazole 33%
• Oral 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Mucormycosis 100%
• Infection 66%
• Sinusitis 66%
• Mucorales 66%
• Necrosis 33%
• Posaconazole 33%
• Triazole Derivative 33%
• Antifungal Agent 33%
• Immunocompromised Patient 33%
• Infarction 33%
• Amphotericin B 33%
• Mould 33%
• Isavuconazole 33%